Film creditsA common unit is not a common study.
A synthesis method for deciding whether independent material or assay studies estimate a sufficiently coherent quantity to justify numerical pooling.
Proposed evidence-engineering direction | External sources and defined methods; scope, rights and delivery capacity to be agreed.
Pooling is a scientific decision first
Establish a coherent scientific question and eligible preparation group before deciding whether a combined estimate would help the application.
A combined estimate can be useful when separate studies address a coherent question, but it can also obscure the differences that matter to an application. The proposed synthesis begins with preparation, endpoint, comparator and operating conditions. It asks what quantity the pooled result would represent and who would use it. A formulation buyer needs a comparison relevant to its material system, not an average of all available positive percentages. If the studies do not estimate a defensible common quantity, an evidence map or a proposed common protocol may provide more value than a mathematically precise but scientifically vague summary.
Examine the development decision
A common unit is not a common study.
Open the sequence to examine what a development decision needs.
Identify the exact preparation, its source, and the properties a second laboratory must be able to reproduce.
Explanatory geometry · no simulated or measured performance
Independent studies and eligible effects
Identify independent studies and compatible effect definitions before selecting weights or treating multiple outputs as separate pieces of evidence.
Deeks et al. (2024) describe meta-analysis as combining results from separate studies with attention to effect measures, bias and heterogeneity. For material research, the same underlying need for a defined comparison remains important, while application-specific eligibility must be developed rather than borrowed mechanically from clinical review practice. Multiple conditions in one study do not automatically become independent studies. The proposed record would identify shared controls, reused specimens and publication versions before weighting anything. It would also require a suitable estimate of precision, not infer one from an unqualified error bar or a large row count.
The current source cases do not support one global average
Use the current source cases to see why different preparations and endpoints belong in distinct comparisons rather than one global average.
Sun et al. (2015) examine EPS preparation and functional assays, whereas Woodbridge et al. (2025) deposit rheological sweeps for different specimens. These sources can inform complementary development questions but do not estimate one pooled ingredient-performance effect. Even several chemical percentages within a paper may have different reaction contexts and denominators. The proposed eligibility map would group genuinely comparable questions and leave the rest as separate evidence branches. That structure gives a buyer a clearer view of what a new common-comparator study might resolve, instead of turning unrelated observations into a ranking of overall material value.
Keep the conditions attached to the result.
Make scientific records useful through source-linked comparisons, explicit units and a reproducible decision trail.
Weighting requires a defined variance
Require a defined positive variance for each eligible estimate before interpreting an inverse-variance average as a precision-weighted result.
For independent estimates of the same effect, a common-effect inverse-variance expression illustrates how precision enters a weighted mean. The expression is not a licence to apply the method to the current mixed source cases. It requires an appropriate variance for each estimate and a scientific interpretation for the combined quantity. Deeks et al. (2024) discuss those choices and the additional assumptions of heterogeneous-effects models. The proposed record would retain the selected effect measure, precision basis and dependence handling, allowing another scientist to reconstruct the synthesis or explain why an alternative grouping is more appropriate.
Combine independent, eligible effect estimates with known standard-error basis.
- Eligible study effect estimateChosen common effect unit
- Standard error of study estimateSame unit as θ_i
- Inverse variance weightInverse square of effect unit
- Weighted estimateChosen common effect unit
Model conditions. Independent eligible estimates Compatible effect definition and common-effect interpretation No pooling performed on the current mixed material cases Every standard error s_i is finite and strictly positive; no zero uncertainty inferred from a missing value
Change the conditions · examine the reference
More readings—or more evidence?
Change the independent preparations and repeat readings. See which source of variation the next measurement can actually reduce.
The data, equations and controls remain available below if 3D cannot load.
Defined model · illustrative conditions
Points are discrete design calculations, joined for comparison. No experimental observations or confidence intervals are shown.
Fund the preparation or repeat that addresses the uncertainty relevant to the development decision.
The defined comparison
Balanced random-intercept scenario with between-preparation SD 10 response AU and within-preparation SD 6 response AU. Preparations are independent; residual readings are independent with common variance. The naive estimate treats all BR readings as independent and ignores clustering. The 3D groups depict a design count, not measured sample values. No confidence interval, power or precision guarantee is calculated. Drift, pairing, operators, serial correlation and unequal group sizes need additional structure.
Inspect the calculated values
Calculation grid, not measured observations. Inputs and assumptions are stated above.
| Independent preparations / count | Hierarchical design | All readings treated as independent |
|---|
Heterogeneity can contain the answer
Investigate whether preparation or measurement differences explain disagreement, preserving potentially useful scientific heterogeneity instead of averaging it away.
Differences in concentration, temperature, purification or readout window may explain why studies disagree. A proposed analysis should preserve those differences rather than treating all variation as an inconvenience to average away. An application team may care specifically about a subgroup of conditions or the likely range of a future preparation, not only the mean reported effect. The evidence map would therefore make experimental diversity visible before statistical heterogeneity is calculated. Where only a few independent studies exist, elaborate moderator models may be unjustified. The useful output may be a testable explanation for disagreement and a small study that discriminates it.
Repeated records require dependence handling
Retain shared controls and repeated experimental units when combining estimates so that one study cannot gain artificial statistical weight.
A study may contribute several conditions measured on the same units or against a shared control. Those records have statistical dependencies that affect uncertainty and weighting. Bland and Altman (1994) provide the underlying warning about mixing repeated observations as though independent. The proposed synthesis would record the study and experimental-unit structure, then choose one eligible effect, an appropriate dependent-effect method or a non-pooling presentation. It would not multiply a source’s apparent contribution by counting every plotted point as an independent study. This matters commercially when a supplier narrative draws heavily on several papers that reuse the same underlying material or experiment.
An honest synthesis can be useful without a diamond
Produce an eligibility and comparison record that remains useful even when the evidence cannot justify a pooled numerical conclusion.
The proposed deliverable would contain search and eligibility boundaries, source records, reasons for exclusion and a comparison structure. Numerical pooling would appear only where its assumptions and meaning could be defended. Otherwise, the report could show condition-specific observations, contradictions and a proposed common protocol. A partner could use that output to decide what evidence is missing before commissioning development work or relying on a material proposition. The paid-service hypothesis is a bounded decision synthesis, not guaranteed statistical certainty or a literature endorsement. Its value should be judged against the decision it helps the buyer make.
The next proposed comparison.
An eligibility map and a justified synthesis or non-pooling record
Making the next study fill a defined gap
Make the next study resolve a named synthesis gap, using a common preparation and protocol where existing evidence cannot align.
If synthesis reveals incompatible preparations, the next experiment should compare feasible materials under one protocol. If endpoints differ, the team may need a shared measured quantity before studying more variants. If independent coverage is sparse, additional preparations or studies matter more than extracting further conditions from the same paper. The proposed next-step record would state which gap prevents the decision and what finding would remove it. This keeps a synthesis commercially useful and scientifically restrained: the reader can see why a new comparison deserves support, and why an apparently impressive pooled number would not yet answer the application question.
Evidence engineering · Proposed development discussion
A development path
for this research.
Whether a pooled estimate is scientifically useful
The people this could serve.Formulation, application-science and research-data teams.
The decision behind the project.
Your intended application, present alternative and the constraint behind “When studies can be pooled”. A useful starting point is the change that would justify another development step.
A proposed scope centred on an eligibility map and a justified synthesis or non-pooling record.
Agree the comparison, acceptance basis and responsible expertise before discussing a paid package.
Specialist methods and a defined contribution.
Bring relevant analytical or experimental expertise, a comparator suggestion, and the conditions under which your method could resolve this question.
A jointly scoped proposal could connect your contribution with an eligibility map and a justified synthesis or non-pooling record.
Define contributions, required access, independent preparations and permitted outputs before work or protected information is shared.
The commercial purpose of the next milestone.
Bring the application or asset thesis, the buyer you expect to value it, and the scientific or commercial uncertainty that must be resolved before another commitment.
The proposed decision record would connect the buyer question with an eligibility map and a justified synthesis or non-pooling record. It would identify what a subsequent comparison needs to demonstrate.
Demand, development cost, resources, rights and a decision-changing milestone would need examination. No financing terms or investment outcome are represented here.
What a useful comparison
would record.
- Record eligible study effect estimate (Chosen common effect unit) with the preparation, method and conditions needed to interpret it.
- Record standard error of study estimate (Same unit as θ_i) with the preparation, method and conditions needed to interpret it.
- Record inverse variance weight (Inverse square of effect unit) with the preparation, method and conditions needed to interpret it.
What the proposed
brief could leave behind.
- An eligibility map and a justified synthesis or non-pooling record
- A preparation, comparator and endpoint record tied to this question.
- A source-linked account of the evidence gaps, study assumptions and next review point.
The proposed discussion brief
A brief you
can take away.
Use non-confidential notes to connect this topic with your own decision. Entries stay in this browser tab; saving creates a text file on your device. Nothing is submitted.
A scoped evidence/data decision brief or qualified comparison programme; recurring or API access only after delivery capacity and repeat buyer value are established.
Notes are optional. The brief includes this page’s proposed question and public source links.
Proposed scope; resources, methods, rights and delivery terms would be agreed before work. Begin with non-confidential information.
Sources and reading notes.
External work is identified below. Access notes describe the material inspected for this page; company research questions and proposed work are not presented as findings from these sources.
Deeks et al, 2024Deeks et al. (2024) Cochrane Handbook chapter 10: Analysing data and undertaking meta-analyses
Effect measures, dependence, weighted synthesis, heterogeneity and sensitivity.
Scope and limitations: Intervention-review methods adapted only at the stated conceptual/statistical level; no clinical review conducted.
Open original sourceSun et al., 2015Sun et al. (2015) Characterization and Biotechnological Potential Analysis of a New Exopolysaccharide from the Arctic Marine Bacterium Polaribacter sp. SM1127
Preparation classes, glycosyl composition and distinct crude-EPS functional assays.
Scope and limitations: External material; not Bio samples, skin efficacy or a complete ingredient specification. Retention condition wording remains unresolved.
Open original sourceWoodbridge et al, 2025Woodbridge et al. (2025) Rheological Characterisation of a Carbopol Microgel and a Commercial Body Lotion: Steady, Oscillatory, and Parallel Superposition Measurements
Acquired six source CSVs: 392 flow, amplitude and frequency rows for two source specimens; source units and README conditions.
Scope and limitations: CC BY 4.0 version 1; two studied specimens, not independent lots or a current commercial product specification. No parallel-superposition or slip data analysed.
Open original sourceBland and Altman, 1994Bland and Altman (1994) Correlation, regression, and repeated data
Separates within- and between-subject questions; repeated measurements are dependent.
Scope and limitations: Statistical note, not evidence of a Bio effect or licence to republish its tables.
Open original source
